Today: 18 July 2026
ARK Buys 147,805 SpaceX Shares as Selloff Accelerates Ahead of Starship Retry
18 July 2026
1 min read

ARK Buys 147,805 SpaceX Shares as Selloff Accelerates Ahead of Starship Retry

NEW YORK, July 18, 2026, 10:13 a.m. EDT

ARK Invest, led by Cathie Wood, boosted its holdings in Space Exploration Technologies Corp. on Friday, purchasing 147,805 shares, according to its daily filing.

The latest purchase was 20% bigger than Wednesday’s acquisition of 122,807 shares, but represented just 0.18% of the volume on Friday.

ARK’s confidence increased. The size of its order was insufficient to provide substantial price backing.

SpaceX dropped 14.7% over the week, ending at $123.99. The Nasdaq declined 2.9%, widening the gap to 11.8 percentage points.

ARK releases trade information after transactions are completed. The firm describes these files as unofficial and unreconciled.

ARK purchase dateShares acquiredSPCX closing priceEstimated value at closeBuy as % of daily volume
Wednesday, July 15122,807$135.27$16.6 million0.21%
Friday, July 17147,805$123.99$18.3 million0.18%

Early estimates for closing values. These figures do not represent reported execution costs.

Trading volume increased by 44% on Friday compared to Wednesday. ARK increased its share purchases, but accounted for a lower proportion of the day’s activity.

The flagship ARK Innovation ETF (BATS:ARKK) acquired 95,129 shares on Friday, comprising 64% of ARK’s total reported activity.

On Friday, ARK sold 5,781 shares of Deere & Co. , after reducing its position by 6,833 shares on Wednesday.

The average target among 33 analysts tracked by Barchart stood at $234.45, suggesting shares could gain 89% from Friday’s closing price. According to Barchart’s data, SpaceX was valued at nearly 95 times trailing sales.

The week’s decline picked up pace following Thursday’s Starship launch abort, when four of 33 booster engines did not ignite.

SpaceX is set to swap out two engines. Elon Musk stated the launch window is “early next week.” The company aims for Monday, July 20. Reuters

Space Capital CEO Chad Anderson described Starship as “the centerpiece” of the long-term thesis. The upcoming test flight will challenge that assessment in public markets. Reuters

Risks stay elevated. Fresh losses could follow another abort, heavy August lock-up supply or further valuation compression. A successful flight might trigger a comparable sharp rebound.

U.S. cash markets remained shut on Saturday. The upcoming flight attempt on Monday is expected to be the key driver. Investors are focusing on execution rather than ARK’s purchases as they look for a sustainable bottom.

Leokadia Głogulska is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, space technology and global market developments. She graduated from Wrocław University of Economics and Business and previously worked in financial analysis before moving into business journalism. Her reporting focuses on helping readers understand the market trends, companies and technologies shaping the global economy.

Stock Market Today

  • CFP and Death Doula Share End-of-Life Financial Strategies
    July 18, 2026, 12:42 PM EDT. A Certified Financial Planner (CFP) who is also a death doula provides specialised guidance for end-of-life financial matters. A serious health diagnosis can disrupt existing financial plans, affecting retirement objectives and asset allocation. Combining expertise from both roles, the CFP-death doula helps people realign financial decisions to address shifting health needs, supporting plans for final expenses and legacy wishes. End-of-life financial planning examines estate documentation, healthcare expenses, and reliable income sources to maintain stability during a health crisis. The CFP and death doula underscores the importance of direct communication and timely financial updates to help reduce family stress.
Iovance Biotherapeutics (NASDAQ:IOVA) shares jump 18% as Amtagvi sales test approaches
Previous Story

Iovance Biotherapeutics (NASDAQ:IOVA) shares jump 18% as Amtagvi sales test approaches

Synopsys (NASDAQ:SNPS) loses $6.3 billion following Kimi K3 chip-design demonstration
Next Story

Synopsys (NASDAQ:SNPS) loses $6.3 billion following Kimi K3 chip-design demonstration

Go toTop